We particularly underscored that DFX is a preferential inhibitor of KLK8, a relevant serine protease in AD, dementias, and other psychiatric disorders, although its selectivity toward trypsin‐like KLKs remains to be optimized. Here, KLK8 is linked to Alzheimer disease.